BCL2 and neoplasm: Gene expression profiling of MM cells treated with ARd results in upregulation of IRF1 [21], which is a tumor suppressor that inhibits BCL2 transcription [40], but increases expression of caspases and enhancement of mitochondrial-mediated tumor cell apoptosis.